Elevance Health, Inc.
For the period ended Sep 30, 2026. Filed Oct 21, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 21, 2026
ELV$425.62-1.5%Stored close · as of Nov 6, 2026
Contents
Item 1. Consolidated Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025
Consolidated Balance Sheets
| September 30,2026 | December 31,2025 | |
|---|---|---|
| (Unaudited) | ||
| (In millions, except share and per share data) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $10,348 | $9,491 |
| Fixed maturity securities (amortized cost of $26,806 and $25,773; allowance for credit losses of $60 and $21) | 25,347 | 25,884 |
| Equity securities | 2,151 | 740 |
| Premium receivables, net | 10,686 | 10,073 |
| Self-funded receivables, net | 6,277 | 5,162 |
| Other receivables | 7,610 | 6,307 |
| Other current assets | 6,105 | 5,344 |
| Total current assets | 68,524 | 63,001 |
| Long-term investments: | ||
| Fixed maturity securities (amortized cost of $1,272 and $1,116; allowance for credit losses of $0 and $0) | 1,211 | 1,121 |
| Other invested assets | 11,508 | 10,839 |
| Property and equipment, net | 4,613 | 4,679 |
| Goodwill | 28,343 | 28,344 |
| Other intangible assets | 10,877 | 11,200 |
| Other noncurrent assets | 2,725 | 2,310 |
| Total assets | $127,801 | $121,494 |
| Liabilities and equity | ||
| Liabilities | ||
| Current liabilities: | ||
| Medical claims payable | $18,438 | $17,084 |
| Other policyholder liabilities | 2,635 | 3,632 |
| Unearned income | 1,637 | 1,493 |
| Accounts payable and accrued expenses | 8,315 | 7,322 |
| Short-term borrowings | — | 150 |
| Current portion of long-term debt | 375 | 1,099 |
| Other current liabilities | 15,262 | 10,255 |
| Total current liabilities | 46,662 | 41,035 |
| Long-term debt, less current portion | 30,382 | 30,797 |
| Deferred tax liabilities, net | 1,487 | 2,110 |
| Other noncurrent liabilities | 4,476 | 3,526 |
| Total liabilities | 83,007 | 77,468 |
| Shareholders’ equity | ||
| Preferred stock, without par value, shares authorized 100,000,000; shares issued and outstanding – none | — | — |
| Common stock, par value $0.01, shares authorized 900,000,000; shares issued and outstanding – 216,113,946 and 220,723,898 | 2 | 2 |
| Additional paid-in capital | 8,987 | 8,938 |
| Retained earnings | 37,368 | 35,393 |
| Accumulated other comprehensive loss | (1,676) | (451) |
| Total shareholders’ equity | 44,681 | 43,882 |
| Noncontrolling interests | 113 | 144 |
| Total equity | 44,794 | 44,026 |
| Total liabilities and equity | $127,801 | $121,494 |
-2-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.